A5DR01
Advisa DR

Device Survival Probability
A2DR01_A3DR01_A5DR01_EN1DR01_SURV
Loading...
1 yr | 2 yr | 3 yr | 4 yr | 5 yr | 6 yr | 7 yr | 8 yr | 9 yr | at 118.0 mo | ||
---|---|---|---|---|---|---|---|---|---|---|---|
% | ![]() |
100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
% | ![]() |
100.0 | 99.9 | 99.9 | 99.8 | 99.7 | 99.4 | 98.8 | 95.9 | 87.9 | 57.1 |
# | 308384 | 290536 | 273794 | 257049 | 237637 | 216768 | 182503 | 109966 | 45804 | 3338 |
- Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
- Excluding Normal Battery Depletion – This is the malfunction free survival curve.

Product Characteristics
Generator Type | IPG |
---|---|
NBD Code | OAE-DDDR |
Max. Delivered Energy | N/A |
Connector Style | IS-1 UNI/BI |
---|---|
Serial Number Prefix | PZL |
Mass | 22g |
Volume | 12.7cc |
Waveform | N/A |
X-Ray ID | PVX |
IS-1 UNI/BI

Estimated Longevity
Amplitude Setting | 500 Lead Ω | 1000 Lead Ω |
---|---|---|
Low 2.5 V (A, RV) | 8.9 | 10.2 |
Nominal 3.5 V (A, RV) | 6.9 | 8.6 |
High 5.0 V (A, RV) | 4.3 | 6.2 |
Longevity estimates based on the following device usage. Pace/Sense Mode DDD ; Atrial Pulse Width 0.4 ms; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; EGM Prestorage ON ; Upper Sensing Rate 130 ppm; Atrial Percent Paced 100 %; EGM Prestorage ON Time 1 ; Atrial Fib Percent of Time 0 %; Hide this content

Distribution Data
US Market Release | |
---|---|
CE Approval Date | 2009-06-02 |
Registered USA Implants | |
Estimated Active USA Implants | |
Normal Battery Depletions |
US Market Release | |
---|---|
CE Approval Date | 2009-06-02 |
Estimated WW Distribution | 31076 |
Normal Battery Depletions |

EOS Indication
The Prolonged Service Period (PSP) is the time between the RRT and EOS. The PSP is defined as 6 months assuming the following conditions: 100% VVI pacing at 60 min–1, 2.5 V RV pacing amplitude; 0.4 ms pulse width; and 600 Ω pacing load. The EOS may be indicated before the end of 6 months if the device exceeds these conditions.
Data as of November 20, 2024